The main goal of BabyLux is to diminish the risk of brain lesions in extremely preterm babies from 25% to 20%, eventually reducing the number of children with disabilities by more than 1,000 per year in Europe alone. With the synergy and joint work of researchers, clinicians and SMEs the project aim to have a significant step forward in this area of public health.

The objectives of the project are:

  • to fill a void in the neonatal intensive care, where there aren’t any reliable tools to assess the brain blood flow and oxygenation in infants born prematurely
  • to monitor non-operative oxygenation and cerebral hemodynamics in premature infants
  • to provide a precise, non-invasive and robust integrated system is the key to enable neonatologists to prevent neurological damages due to lack of oxygenation in the brain
  • to extend the prototype to the level of demonstrator, bridging the gap between research products and commercialization


CIP

BabyLux is a project funded by the European Union under the Competitiveness and Innovation Framework Programme 2007-2013 (Grant agreement n. 620996)